(3-Acryloxypropyl)tris(trimethylsiloxy)silane inhibited with MEHQ tech-95, 95+%, 25g

methyl 3-(4-chloro-3-methylphenyl)-1H-pyrazole-5-carboxylate, 98%, 500mg

2-Chlorooxazole-4-carboxamide, 95+%, 50mg

1-[4-(Trifluoromethyl)benzyl]-3,5-dimethyl-1H-pyrazole-4-carboxylic acid, >95%, 1g

Butylmalonic Acid>98.0%(GC)(T)5g

4-(Aminomethyl)pyridin-2(1H)-one hydrochloride, 95.0%, 5g

1,4-Cyclohexanediol (cis- and trans- mixture)>99.0%(GC)25g

6-((tert-Butoxycarbonyl)amino)imidazo[1,5-a]pyridine-1-carboxylic acid, 98%, 1g

Methyl 3-(((tert-butyldiphenylsilyl)oxy)methyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 100mg

2,2'-Thiobis(4-chlorophenol), 95.0%, 25g

2-Fluorocyclopropanecarboxylic acid, 95.0%, 5g

Nitrate de potassium, min.99%, Ph. Eur., BP, 5 kg, emballage plastique.

(1S,2S)-2-(1-Pyrrolidinyl)cyclohexanamine, 97%, 1g